InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PepGen Inc.

PEPG Clue Score35
United States Fiscal year ends December CIK 0001835597 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Oxford Science Enterprises plc
30 Sep 2025
Former 10% Owner
Buy
200,000
$3.20
$640.00K
Ra Capital Management, L.p.
26 Sep 2025
Director
Buy indirect
9,375,000
$3.20
$30.00M
Paul Streck
30 May 2025
EVP, Head of R&D
Buy
8,375
$1.24
$10.39K
James G McArthur
17 Apr 2025
President and CEO
Buy
10,000
$1.36
$13.55K
James G McArthur
8 Apr 2025
President and CEO
Buy
41,500
$1.15
$47.73K
Ra Capital Management, L.p.
9 Feb 2024
Director
Buy indirect
2,557,593
$10.64
$27.21M
James G McArthur
30 Nov 2023
President and CEO
Buy
1,694
$4.17
$7.06K
James E Flynn
10 May 2022
10% owner
Buy indirect
208,333
$12.00
$2.50M
James E Flynn
10 May 2022
10% owner
Buy indirect
208,333
$12.00
$2.50M
Ra Capital Management, L.p.
10 May 2022
Director
Buy indirect
249,749
$12.00
$3.00M
Ra Capital Management, L.p.
10 May 2022
Director
Buy indirect
2,979,451
$12.00
$35.75M
Laurie Keating
6 May 2022
Director
Buy
4,166
$12.00
$49.99K
Show all 44 transactions →

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 9,848,749
History held since 10 May 2022